A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens
Mycobacterium tuberculosis infection is still a major global public health problem. Presently the only tuberculosis (TB) vaccine available is Bacille Calmette-Guérin (BCG), although it fails to adequately protect against pulmonary TB in adults. To solve this problem, the development of a new effecti...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2014/395626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850167586037170176 |
|---|---|
| author | Miao Lu Zhi Yang Xia Lang Bao |
| author_facet | Miao Lu Zhi Yang Xia Lang Bao |
| author_sort | Miao Lu |
| collection | DOAJ |
| description | Mycobacterium tuberculosis infection is still a major global public health problem. Presently the only tuberculosis (TB) vaccine available is Bacille Calmette-Guérin (BCG), although it fails to adequately protect against pulmonary TB in adults. To solve this problem, the development of a new effective vaccine is urgently desired. BCG-prime DNA-booster vaccinations strategy has been shown to induce greater protection against tuberculosis (TB) than BCG alone. Some studies have demonstrated that the two genes (Rv1769 and Rv1772) are excellent T-cell antigens and could induce T-cell immune responses. In this research, we built BCG-C or BCG-P prime-recombination plasmid PcDNA3.1-Rv1769 or PcDNA3.1-Rv1772 boost vaccinations strategy to immunize BALB/c mice and evaluated its immunogenicity. The data suggests that the BCG-C+3.1-72 strategy could elicit the most long-lasting and strongest Th1-type cellular immune responses and the BCG-C+3.1-69 strategy could induce the high level CD8+ T-cell response at certain time points. These findings support the ideas that the prime-boost strategy as a combination of vaccines may be better than a single vaccine for protection against tuberculosis. |
| format | Article |
| id | doaj-art-e786f3615362498aafebb20ff4f668d2 |
| institution | OA Journals |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-e786f3615362498aafebb20ff4f668d22025-08-20T02:21:10ZengWileyJournal of Immunology Research2314-88612314-71562014-01-01201410.1155/2014/395626395626A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis ImmunogensMiao Lu0Zhi Yang Xia1Lang Bao2Laboratory of Infection and Immunity, School of Basic Medical Science, West China Center of Medical Sciences, Sichuan University, No. 17, Third Section, Ren Min Nan Road, Chengdu, Sichuan 610041, ChinaLaboratory of Infection and Immunity, School of Basic Medical Science, West China Center of Medical Sciences, Sichuan University, No. 17, Third Section, Ren Min Nan Road, Chengdu, Sichuan 610041, ChinaLaboratory of Infection and Immunity, School of Basic Medical Science, West China Center of Medical Sciences, Sichuan University, No. 17, Third Section, Ren Min Nan Road, Chengdu, Sichuan 610041, ChinaMycobacterium tuberculosis infection is still a major global public health problem. Presently the only tuberculosis (TB) vaccine available is Bacille Calmette-Guérin (BCG), although it fails to adequately protect against pulmonary TB in adults. To solve this problem, the development of a new effective vaccine is urgently desired. BCG-prime DNA-booster vaccinations strategy has been shown to induce greater protection against tuberculosis (TB) than BCG alone. Some studies have demonstrated that the two genes (Rv1769 and Rv1772) are excellent T-cell antigens and could induce T-cell immune responses. In this research, we built BCG-C or BCG-P prime-recombination plasmid PcDNA3.1-Rv1769 or PcDNA3.1-Rv1772 boost vaccinations strategy to immunize BALB/c mice and evaluated its immunogenicity. The data suggests that the BCG-C+3.1-72 strategy could elicit the most long-lasting and strongest Th1-type cellular immune responses and the BCG-C+3.1-69 strategy could induce the high level CD8+ T-cell response at certain time points. These findings support the ideas that the prime-boost strategy as a combination of vaccines may be better than a single vaccine for protection against tuberculosis.http://dx.doi.org/10.1155/2014/395626 |
| spellingShingle | Miao Lu Zhi Yang Xia Lang Bao A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens Journal of Immunology Research |
| title | A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens |
| title_full | A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens |
| title_fullStr | A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens |
| title_full_unstemmed | A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens |
| title_short | A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens |
| title_sort | mycobacterium bovis bcg naked dna prime boost vaccination strategy induced cd4 and cd8 t cell response against mycobacterium tuberculosis immunogens |
| url | http://dx.doi.org/10.1155/2014/395626 |
| work_keys_str_mv | AT miaolu amycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens AT zhiyangxia amycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens AT langbao amycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens AT miaolu mycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens AT zhiyangxia mycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens AT langbao mycobacteriumbovisbcgnakeddnaprimeboostvaccinationstrategyinducedcd4andcd8tcellresponseagainstmycobacteriumtuberculosisimmunogens |